Human Recombinant Apyrase Therapy Protects Against Myocardial Ischemia/Reperfusion Injury and Preserves Left Ventricular Systolic Function in Rats, as Evaluated by 7T Cardiovascular Magnetic Resonance Imaging.

CONCLUSION: APT102 can significantly alleviate damage to the ischemic myocardium and microvasculature. IMH size peaked at 48 hours post reperfusion and IMH is a downstream consequence of MVO. IMH may be a potential therapeutic target to prevent adverse remodeling in MI. PMID: 32410404 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32410404?dopt=Abstract

Source: Korean Journal of Radiology - May 17, 2020 Category: Radiology Tags: Korean J Radiol Source Type: research